Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We project Crossflo/Iameter profitability by fiscal year 2009 Q4 (May 2009)

We project Crossflo/Iameter profitability by fiscal year 2009 Q4 (May 2009)

posted on Jan 03, 2009 06:44AM

how much revenue would Crossflo/Iameter have to produce to be profitable by May 2009?

Share
New Message
Please login to post a reply